Cornell’s Research Serves the Region and Beyond

Acuamark Diagnostics Inc. CTL

Early Detection Molecular Diagnostics

  • Products:
  • Colorectal Cancer Early Detection Test
  • Pan-Oncology Early Detection Test

Acuamark Diagnostics Inc. develops technology which allows for the highly accurate screening of blood to detect cancer markers at the early cancer stages before the cancer becomes untreatable. The company is backed by a highly experienced team of scientific and business professionals. It is their mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, and early detection.

Cornell Connection

Acuamark Diagnostics' foundational technology was developed by a professor at Weill Cornell Medicine. The company's foundational technology is licensed from Cornell University.